Gray Matters from Epilepsia

2020 Gray Matters

October 2020

• Announcements of future congresses and courses

September 2020

• Letter: The prevalence of genetically diagnosable epilepsies in young
  adulthood: How many should we be looking for?
• Letter: Genetic testing in adult epilepsy patients: A call to action for clinicians

August 2020

• Letter: Misperceptions on the chance of seizure freedom with antiseizure
  medications after two failed trials
• Letter and Response: Cannabidiol antiseizure activity and its interactions with
  clobazam: “It’s déjà vu all over again” Yogi Berra
• Letter: Cannabidiol efficacy and clobazam coadministration: Where do
  we stand now?
• Letter: Epilepsy gene panel yield and impact on outcomes for adults with
  unexplained seizures